Royalty Pharma: Q1 Earnings Insights

Royalty Pharma RPRX reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Royalty Pharma missed estimated earnings by 17.81%, reporting an EPS of $0.6 versus an estimate of $0.73.

Revenue was down $11.03 million from the same period last year.

Last quarter the company beat on EPS by $0.03 which was followed by a 0.4% increase in the share price the next day.

Here's a look at Royalty Pharma's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	0.77	0.69	0.69	0.65
EPS Actual	0.80	0.24	0.73	0.18
Revenue Estimate	556.79M	578.20M	483.42M	509.70M
Revenue Actual	576.00M	585.77M	555.00M	573.03M

To track all earnings releases for Royalty Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar